CEO Blog

The gerontological research community should be proud of the way it has responded to the need for study of the COVID-19 pandemic. The work of many scholars has resulted in dozens of articles on the topic appearing in GSA’s journals, and this has resulted in several important new themed collections and special issues.

The February and March issues of The Gerontologist are special issues made up of invited papers under the theme of “Gerontology in a Time of Pandemic.” (Following the call for papers, the editorial team received 132 submissions from 25 different countries!)

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences — GSA’s top-rated journal as measured by impact factor for 10 years running — has introduced a new feature within its biological sciences pages that will be of interest to all members. The recently launched Fellows Forum enhances the journal’s connections to the GSA membership by providing a platform for fellows in our Biological Sciences Section to share their insights and experience in the field of aging biology.

The next few weeks at GSA offer some prime opportunities to share your science! Not only are we accepting abstracts for the 2021 Annual Scientific Meeting (until March 11), but GSA’s journals have three open calls for submissions across a wide range of disciplines.

GSA is now accepting abstract submissions for this November’s Annual Scientific Meeting! This is your chance to advance the science of aging — and as we take stock of the past year’s upheavals, we find that science was one of few arenas that brought us significant hope.

While the development of new COVID-19 vaccines may be the achievement most people remember from this time, there were critical advances in other important areas, too. National Institutes of Health (NIH) Director, Dr. Francis Collins, recently authored a blog highlighting many of them.

The U.S. is back as a full-fledged member of the World Health Organization (WHO) — and that bodes well for bringing a quicker end to the pandemic, the success of the “Decade of Healthy Ageing,” and many other things.

One of the first acts of Joe Biden’s presidency was to retract the withdrawal from WHO enacted by the previous administration. And for the icing on the cake, National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci has been tapped to represent the U.S. on the WHO Executive Committee.